This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Allscripts Announces Open App Challenge Award Recipients

Challenge Details

Allscripts recognized entries in the following categories:

  • Applications that improve management of high cost chronic diseases 
  • Innovative approaches to addressing value-based care

All participants who submitted an entry for Phase 1 will advance to Phase 2 of the challenge. In Phase 2, Allscripts will award $250,000 for the application that demonstrates the most positive clinical, financial or performance improvement results after deployment at a client site. Two runners-up each receive $100,000; another two runners-up each receive $75,000. Second-round submissions are due July 14, 2013.

Allscripts will announce the final recipients at the Allscripts Client Experience (ACE) in Chicago, August 21-23, 2013. Second-round contestants must be accepted into Allscripts Developer Program before submitting their application. Winning solutions must demonstrate integration with the Allscripts Sunrise Clinical Manager™, Allscripts Enterprise Electronic Health Record™ (EHR) or Allscripts Professional™ EHR.

To learn more about the challenge, click here.

To follow the challenge on the Allscripts blog, click here.

About Allscripts Developer Program (ADP)

The Allscripts Developer Program enables outside developers to build innovations for clients and get them tested and approved to run on Allscripts Electronic Health Records. For example, MyCareTeam created an app where providers can access reports on their diabetic patients from the Allscripts Electronic Health Record, which include blood glucose readings as well as progress on diet and exercise, so caregivers can easily monitor a patient's progress against the treatment plan, and patients feel more engaged in their own health.

About Allscripts

Allscripts (NASDAQ:  MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a  Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit  www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About Health 2.0

Health 2.0--The conference. The media network. The Innovation Community. The Health 2.0 Conference is the leading showcase of cutting-edge technologies in health care, including Online Communities, Search and lightweight Tools for consumers to manage their health and connect to providers online. The Health 2.0 Developer Challenge is a series of prize competitions promoting health technology innovation. Health 2.0 also has its own media channels, Health 2.0 News and Health 2.0 TV; its own market intelligence service, Health 2.0 Advisors; and also sponsors the Health 2.0 Accelerator industry consortium. Health 2.0 was founded by Indu Subaiya & Matthew Holt in 2007 and is now a community of hundreds of organizations and thousands of innovators.  For more information, see www.health2con.com.

© 2013 Allscripts Healthcare, LLC

Stock quotes in this article: MDRX 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,262.56 +89.32 0.55%
S&P 500 1,842.98 +12.37 0.68%
NASDAQ 4,034.1610 +11.4670 0.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs